Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$8,486,661
+$326,765 QoQ
Shares Held
33,416
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
#1,206
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026West Branch Capital LLC holds $28,624,658 across 10 Drug Manufacturers - General names. JNJ ranks #2 (29.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,703 | $10,438,640 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
33,416 | $8,486,661 | |
| 3 | ABBV |
AbbVie Inc.
|
30,433 | $7,658,160 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,301 | $1,066,678 | |
| 5 | AMGN |
Amgen Inc
|
1,167 | $422,594 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,186 | $276,179 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,350 | $135,407 | |
| 8 | PFE |
Pfizer Inc
|
4,359 | $104,964 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,486,661 | 33,416 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $8,159,896 | 33,382 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $6,928,892 | 33,481 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $6,127,945 | 33,049 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,968,957 | 32,530 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $4,212,336 | 25,400 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,403,487 | 23,534 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $4,033,673 | 24,890 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $3,537,364 | 24,202 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,789,757 | 23,957 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,567,715 | 22,762 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $3,705,448 | 23,791 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $3,929,610 | 23,741 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,587,630 | 23,146 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $4,065,246 | 23,013 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,753,196 | 22,975 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,022,199 | 22,659 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,058,567 | 22,900 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $4,013,815 | 23,463 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $3,776,354 | 23,383 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,871,719 | 23,502 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $3,793,198 | 23,080 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,690,088 | 23,447 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,455,058 | 23,207 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,249,115 | 23,104 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $2,408,989 | 18,371 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||